Invention Grant
- Patent Title: Yeast-based immunotherapy and type I interferon sensitivity
-
Application No.: US17007908Application Date: 2020-08-31
-
Publication No.: US11304996B2Publication Date: 2022-04-19
- Inventor: Donald Bellgrau , Thomas H. King
- Applicant: GLOBEIMMUNE, INC. , THE REGENTS OF THE UNIVERSITY OF COLORADO, a body corporate
- Applicant Address: US CO Louisville; US CO Denver
- Assignee: GLOBEIMMUNE, INC.,THE REGENTS OF THE UNIVERSITY OF COLORADO, a body corporate
- Current Assignee: GLOBEIMMUNE, INC.,THE REGENTS OF THE UNIVERSITY OF COLORADO, a body corporate
- Current Assignee Address: US CO Louisville; US CO Denver
- Agency: Sheridan Ross P.C.
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K36/064 ; G01N33/573
Abstract:
Disclosed are methods of treating individuals with yeast-based immunotherapy who have been preselected as being sensitive to type I interferons, as well as methods for selecting individuals for treatment with yeast-based immunotherapeutic compositions and methods for enhancing or improving an individual's response to yeast-based immunotherapy, based on the individual's sensitivity to type 1 interferons (T1IFNs).
Information query
